Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company that specializes in the development of innovative therapies for rare diseases. With a focus on unmet medical needs, Mereo utilizes strategic partnerships and a diverse portfolio to advance breakthrough treatments. Their commitment to precision medicine and patient-centric care positions them as a leader in the industry.
